跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Piostal-15
Approved
STANDARD
Piostal-15
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ee24f5ebcc3917f0
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
ee24f5ebcc3917f0
Drug Approval Philippines Name
Piostal-15
Product Name
Piostal-15
Registration Number
DRP-2167
Brand Name
Piostal-15
Generic Name
Pioglitazone (as Hydrochloride)
Dosage Form
Tablet
Dosage Strength
15 mg Tablet
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
28 September 2022
Expiry Date
13 May 2028
Pharmacologic Category
Oral Hypoglycemic Agents (Thiazolidinediones)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ee24f5ebcc3917f0
Type
Standard
Back to Philippines FDA Approvals
Piostal-15 - Philippines FDA Drug Approval Details